164 related articles for article (PubMed ID: 11120955)
1. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
Rocchetta HL; Boylan CJ; Foley JW; Iversen PW; LeTourneau DL; McMillian CL; Contag PR; Jenkins DE; Parr TR
Antimicrob Agents Chemother; 2001 Jan; 45(1):129-37. PubMed ID: 11120955
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of bioluminescent Escherichia coli in a cutaneous wound infection model for evaluation of an antibiotic therapy.
Jawhara S; Mordon S
Antimicrob Agents Chemother; 2004 Sep; 48(9):3436-41. PubMed ID: 15328108
[TBL] [Abstract][Full Text] [Related]
3.
Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
[TBL] [Abstract][Full Text] [Related]
4. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Meinen JB; McClure JT; Rosin E
Am J Vet Res; 1995 Sep; 56(9):1219-24. PubMed ID: 7486402
[TBL] [Abstract][Full Text] [Related]
6. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a multi-dose neutropenic rat thigh infection model using real-time monitoring of Staphylococcus aureus growth in vivo.
Zhang H; Kalkeri G; Mani N; Grossman TH
In Vivo; 2008; 22(6):667-72. PubMed ID: 19180989
[TBL] [Abstract][Full Text] [Related]
8. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
Opal SM; Palardy JE; Parejo N; Jasman RL
Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
[TBL] [Abstract][Full Text] [Related]
11. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli.
Hu Y; Coates AR
FEMS Microbiol Lett; 2005 Feb; 243(1):117-24. PubMed ID: 15668009
[TBL] [Abstract][Full Text] [Related]
12. Horse species symposium: a novel approach to monitoring pathogen progression during uterine and placental infection in the mare using bioluminescence imaging technology and lux-modified bacteria.
Ryan PL; Christiansen DL; Hopper RM; Walters FK; Moulton K; Curbelo J; Greene JM; Willard ST
J Anim Sci; 2011 May; 89(5):1541-51. PubMed ID: 21239661
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
Sohn DW; Han CH; Jung YS; Kim SI; Kim SW; Cho YH
Int J Antimicrob Agents; 2009 Sep; 34(3):215-9. PubMed ID: 19375896
[TBL] [Abstract][Full Text] [Related]
14. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms.
Marques CN; Salisbury VC; Greenman J; Bowker KE; Nelson SM
J Antimicrob Chemother; 2005 Oct; 56(4):665-71. PubMed ID: 16105852
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
[TBL] [Abstract][Full Text] [Related]
17. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
18. Drug-resistant diarrheogenic Escherichia coli, Mexico.
Estrada-García T; Cerna JF; Paheco-Gil L; Velázquez RF; Ochoa TJ; Torres J; DuPont HL
Emerg Infect Dis; 2005 Aug; 11(8):1306-8. PubMed ID: 16102327
[TBL] [Abstract][Full Text] [Related]
19. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli.
Wu G; Fan X; Li L; Wang H; Ding J; Hongbin W; Zhao R; Gou L; Shen Z; Xi T
Int J Antimicrob Agents; 2010 Mar; 35(3):250-4. PubMed ID: 20045294
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and pattern of antimicrobial susceptibility in Escherichia coli isolated from pigs reared under antimicrobial-free and conventional production methods.
Bunner CA; Norby B; Bartlett PC; Erskine RJ; Downes FP; Kaneene JB
J Am Vet Med Assoc; 2007 Jul; 231(2):275-83. PubMed ID: 17630898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
